Download Databook
Download Sample
Table of Content
NA : +1 804 441 9344
sales@towardshealthcare.com
Schedule a Meeting
May 2025
Principal Consultant
Reviewed By
The global lab automation market size is calculated at USD 7.87 in 2024, grew to USD 8.39 billion in 2025, and is projected to reach around USD 15 billion by 2034. The market is expanding at a CAGR of 6.67% between 2025 and 2034.
| Metric | Details |
| Market Size in 2025 | USD 8.39 Billion |
| Projected Market Size in 2034 | USD 15 Billion |
| CAGR (2025 - 2034) | 6.67% |
| Leading Region | North America |
| Market Segmentation | By Process type, By Automation Type, By End-use Type, By Region |
| Top Key Players | QIAGEN, PerkinElmer Inc., Thermo Fisher Scientific, Inc., Siemens Healthcare GmbH, Danaher, Agilent Technologies, Inc., Eppendorf SE, Hudson Robotics, Aurora Biomed Inc., BMG LABTECH GmbH, Tecan Trading AG, Hamilton Company, F. Hoffmann-La Roche Ltd |
Lab automation involves the application of technology and automated processes to simplify and upgrade the various laboratory processes, as they enhance efficiency, lessen the hands-on approach, and increase accuracy and outcomes. Approach towards the robotics technique, fueled by the demand for automated repetitive and labor-intensive tasks, which reduces the manual error, enhances the accuracy, and output. As well, lab automation has been incorporated in different sectors like drug discovery, diagnostics, and research, which will lead to significant growth of the lab automation market in 2025.
Lab automation with AI offers a high rate of accuracy and reliability in handling microtiter-scale sample volumes in upstream procedures. This also assists in preparing several samples for bioanalysis by reducing manual errors. In case of downstream processes, AI-aided automation is highly employed to capture the electronic data and store the protocols, data generated during lab studies.
Enhancing Productivity and Reducing Human Error
As the lab automation market is impelled by demand for high efficiency, accuracy, and rate of output in numerous areas like drug discovery, clinical diagnostics, and genomics. However, rising healthcare expenses, escalating prevalence of chronic diseases, and developments in diagnostics are also contributing as drivers for the lab automation market. Furthermore, lab automation is also applied in laboratory equipment to raise the efficiency in some kinds of processes as labelling tubes, handling, verifications, and reducing human error, and also offers an enhancement in the productivity.
High Expenditure and Maintenance
For the small-scale labs, it is difficult to invest a high amount at the initial level in equipment, software, and implementation services, which acts as an obstacle. Also, developing maintenance and repair expenses are significant, leading to a raise initial equipment expenditure. The sustained documentation for expenditure in lab automation is not always feasible, which increases the hurdles to the lab in the justification of the investment without strong proof of return.
Leading Advancement in the Pharmaceutical and Biotechnological Sector
The lab automation market has various opportunities in the pharmaceutical sector as they are incorporating advanced technologies in the research and development department, to increase the efficiency and accuracy in laboratory approaches. By using these technologies, the drug discovery process in pharmaceutical industries improves the precision and efficiency of drug manufacturing. In the biotechnology sector, lab automation operates to produce high-quality cells in increased quantities.
By process type, the continuous flow segment held the largest share in 2024, as it is fueled by extensive acceptance in laboratories for high-quality services and its applicability for examining various samples with less chemistry. Furthermore, in pharmaceutical and biotechnology companies, the continuous flow processes have increased demand, and also, market companies are introducing novel outcomes related to this market, which leads to the growth of the market.
By process type, the discrete processing segment is expected to grow at the fastest rate in the market during the forecast period. In the discrete processing, it provides plenty of space for the sample analysis by reducing the instances of reagent wastages, which is a significant application over the continuous flow. Hence, various advantages of this segment are predicted to drive the thriving growth during the forecast period in the lab automation market.
By end use, the clinical chemistry labs segment held the largest market share in 2024. Due to technological advancements, there is a rise in demand for automated laboratory instruments, and increased preference for sample handling, storage, and labelling is contributing to the major share of the market.
For instance,
By end use, the immunoassay analysis segment is estimated to grow at the fastest rate in the market during the forecast period. Enhanced accuracy, time and cost consuming, simplified data management and integration with increased efficiency, these several advantages are leading to the fastest growing segment in the lab automation market.
By automation type, the modular automation systems segment dominated the market in 2024. By modular automation systems, the major share is estimated as it is associated with abilities and flexibility capabilities that are provided. This segment is impelled by factors like enhanced throughput screen demand, economic, and applied to reduce the errors in clinical and research applications.
By automation type, the total automation segment is predicted to grow at the fastest rate during the forecast period. In laboratory processes, novel automated systems provide personalized services that are predicted to assist the market growth.
North America dominated the lab automation market in 2024. It is impelled by the need for increased throughput screening, R and D spending, and technological advancements in the market. The region is having high-level funding from the government and private sector for R&D, leading to market growth, with an encouraging regulatory environment with fewer obstacles.
In the U.S, the market is sustaining significant growth, which is fueled by the progression of biopharmaceutical industries, shortage of personnel, and a rising need for highly accurate and faster testing solutions. The research institutions, universities, and government laboratories are using lab automation to increase the precision levels and output of the processes. Also, the U.S government has taken encouraging steps towards healthcare by adopting automated advanced technologies. Furthermore, the smooth acquisition of new technologies such as AI and robotics raises the market growth.
Canada is facing strong growth in its respective market, as it involves some key factors like rising pharmaceutical and R&D, expanding need for automated labs, and the increasing prevalence of chronic diseases. Lab automation workstations and automated plate handlers are playing a crucial role in this market.
Asia Pacific is estimated to host the fastest-growing lab automation market during the forecast period. Including rising improved healthcare infrastructure, increasing consumable incomes, and growth of the pharmaceutical and biotechnology industries, to reduce the expenses, increase the accuracy level, and quicken the diagnostic procedures.
In Japan, pharmaceutical companies are approaching these automations to simplify the drug discovery and development. To reduce the human workforce and increase the accuracy of the testing, various automated systems are used, like automated liquid handling systems, robotics compound libraries, and consolidated screening platforms.
India has shown significant growth impelled by enhanced demand for accuracy and efficiency in laboratories. The government of India has been encouraging initiatives like "Make in India," which is promoting for embrace of advanced technologies such as lab automation. The market in India is boosted by enhanced healthcare facilities and the rise of numerous medical centers with developed and advanced laboratories. Also, the technological revolution has occurred in the biomedical and pharmaceutical industries.
The European market is predicted to grow significantly, influenced by factors like the need for efficient and accurate laboratory reports and technological advancements. In the market, the enhanced healthcare needs are the major factor for rising competition between the healthcare and pharmaceutical companies. The European market is highly focused on the use of sophisticated equipment, analyzers, and software to assist the development in the development of automated laboratory infrastructure.
The market in Germany is influenced by high-throughput screening, which is a crucial process in drug discovery and biotechnology, and permits researchers to examine several compounds for their potential pharmaceutical effects rapidly. Automated equipment raises the HTS by improving the screening process, reducing the human workforce, and reducing errors. This has significance in different fields such as testing of infectious disease, which gives well-timed reports that can affect patient responses and public health outcomes, leading to market growth.
The UK has adopted and consolidated automated systems and technologies to increase the outputs, precision, and efficiency in several scientific areas. This market comprises a diversity of technologies like automated liquid handling systems, analytical instruments, robotic systems, laboratory information management systems (LIMS), and data analysis software. Meanwhile, demand for lab automation has been impelled by innovations in artificial intelligence (AI), machine learning, and IoT (Internet of Things), which have empowered sophisticated laboratory management.
In April 2025, QIAGEN announced the advanced plans for the launch of three new sample preparation instruments in 2025 and 2026 to raise and boost its portfolio for automated sample preparation. Nitin Sood, Senior Vice President and Head of Product Portfolio & Innovation at QIAGEN, replied that these new sample preparation systems emphasize their devotion to assisting in governing more efficiently, ecologically, and flexibly. (Source - STOCK TITAN)
By Process type
By Automation Type
By End-use Type
By Region
May 2025
May 2025
May 2025
May 2025